|
Title
|
Published
|
Price
|
|
Global Biosimilars: A return to optimism?
By: Espicom Healthcare Intelligence
Despite some commentators predicting a muted or near nonexistent market for advanced biosimilars, many companies - and some surprising names - are positioning themselves for market entry.
|
more...
Search inside this report
|
1/23/2012
|
$2,265.00
|
|
Evolution in the Pain Therapy Drugs Market:
By: Espicom Healthcare Intelligence
... of the population suffers from chronic pain. As the population ages, the number of people with chronic pain is increasing, particularly from conditions such as osteoarthritis. Chronic pain is also associated with cancer. An estimated ...
|
more...
Search inside this report
|
1/5/2012
|
$2,265.00
|
|
Hitachi Medical Device Company Intelligence Report
By: Espicom Healthcare Intelligence
... on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical ...
|
more...
Search inside this report
|
12/31/2011
|
$515.00
|
|
Generic Drugs: Global Collaboration Opportunities
By: Espicom Healthcare Intelligence
... to a wider audience. This, allied to the rising cost of new advanced branded products, led to rapid expansion of the generics sector. Even markets traditionally based in the provision of branded medicines have made ...
|
more...
Search inside this report
|
12/2/2011
|
$1,040.00
|
|
Covidien Medical Device Companies Analysis
By: Espicom Healthcare Intelligence
... on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical ...
|
more...
Search inside this report
|
11/30/2011
|
$515.00
|
|
Medtronic Medical Device Companies Analysis
By: Espicom Healthcare Intelligence
... on products, international activities and R&D, as well as a full, in-depth five year financial analysis. An introduction to each report and a full table of contents is provided for review. More than 60 Medical ...
|
more...
Search inside this report
|
11/30/2011
|
$515.00
|
|
Telemonitoring: Challenges & Opportunities
By: Espicom Healthcare Intelligence
... provision. Patient monitoring, observation and diagnosis, no longer rooted in the consulting room, provides 24- hour surveillance and timely clinical interventions when conditions deteriorate. And telemonitoring products are delivering these services across a range of ...
|
more...
Search inside this report
|
11/17/2011
|
$1,740.00
|
|
The Guide to Distributors of Medical Equipment & Supplies Worldwide 2011
By: Espicom Healthcare Intelligence
... Quality: All information provided in this report is verified by the agent or distributors Extensive Content: Much more than a simple address listing with key information on staffing sectors covered, companies represented and products they ...
|
more...
|
11/10/2011
|
$905.00
|
|
The Guide to Distributors of Medical Equipment & Supplies Worldwide 2011 Volume III:Americas
By: Espicom Healthcare Intelligence
... achieve sales success. And in export markets that requires local business and cultural knowledge - knowledge that can be effectively found via sales agents and distributors. Please Note: this is delivered as a Zip file.
|
more...
|
11/10/2011
|
$395.00
|
|
The Guide to Distributors of Medical Equipment & Supplies Worldwide 2011 Volume IV:Asia/Pacific
By: Espicom Healthcare Intelligence
... achieve sales success. And in export markets that requires local business and cultural knowledge - knowledge that can be effectively found via sales agents and distributors. Please Note: this is delivered as a Zip file.
|
more...
|
11/10/2011
|
$395.00
|
|
The Guide to Distributors of Medical Equipment & Supplies Worldwide 2011 Volume II:Middle East/Africa
By: Espicom Healthcare Intelligence
... achieve sales success. And in export markets that requires local business and cultural knowledge - knowledge that can be effectively found via sales agents and distributors. Please Note: this is delivered as a Zip file.
|
more...
|
11/10/2011
|
$395.00
|
|
The Libyan Medical Market: Status & Post-Conflict Opportunities
By: Espicom Healthcare Intelligence
... a more liberal democratic government, it is time to take stock of Libya's position in the medical market economies of the region, examine how it might develop and assess the impacts for medical technology companies.
|
more...
Search inside this report
|
11/8/2011
|
$690.00
|
|
The Outlook for Pharmaceuticals in South East Asia
By: Espicom Healthcare Intelligence
... by both contrasting and similar macroenvironments. These markets are projected to have a total pharmaceutical market value of US$77.4 billion at retail prices in 2016. Please note, this file is delivered as an Zip file.
|
more...
|
11/4/2011
|
$3,490.00
|
|
The Outlook for Pharmaceuticals in Latin America
By: Espicom Healthcare Intelligence
The strong pharmaceutical market growth opportunities and regulatory developments are making Latin America more attractive. Please note, this file is delivered as an Zip file.
|
more...
|
11/4/2011
|
$3,490.00
|
|
The Outlook for Pharmaceuticals in the Middle East and North Africa
By: Espicom Healthcare Intelligence
... five MENA markets covered in this collection will represent a combined GDP of US$2.5 trillion in 2016, led by Turkey and Saudi Arabia. Economic development is changing the epidemiological health profile in the region, with ...
|
more...
|
11/4/2011
|
$3,490.00
|
|
The Outlook for Pharmaceuticals in North East Asia
By: Espicom Healthcare Intelligence
... potential for pharmaceutical manufacturers. China and Japan will be the largest and second largest pharmaceutical markets in the Asia Pacific region covered by Espicom in 2016. Please Note: this is delivered as a Zip file.
|
more...
|
11/4/2011
|
$3,490.00
|
|
The Outlook for Pharmaceuticals in Brazil, Russia, India & China
By: Espicom Healthcare Intelligence
... emerging economies represent a combined pharmaceutical market of US$127.0 billion at retail prices. Where do commercial opportunities exist for pharmaceutical companies over the 2011-2016 forecast period? Please Note: this is delivered as a Zip file.
|
more...
|
11/4/2011
|
$3,490.00
|
|
The Outlook for Pharmaceuticals in Central Asia
By: Espicom Healthcare Intelligence
... and corporate developments in the wider context of market structure, service and access. The reports are available individually, or as a discounted collection, and prices include 4 completely updated reports sent quarterly, plus comprehensive report ...
|
more...
|
11/4/2011
|
$3,490.00
|
|
The Outlook for Pharmaceuticals in Central & Eastern Europe
By: Espicom Healthcare Intelligence
... by a moderate CAGR of 7.7% in US dollar terms over the next few years as the region's economies recover from the global economic crisis. Please note, this file is delivered as an Zip file.
|
more...
|
11/4/2011
|
$3,490.00
|
|
E7: The Outlook for Pharmaceuticals to 2012
By: Espicom Healthcare Intelligence
... consequence of this increasing wealth is a growing financial capacity to treat previously unmet health needs. Another is increasing incidence of 'affluence' diseases such as diabetes, as people live longer and have more sedentary lifestyles. ...
|
more...
|
11/4/2011
|
$3,490.00
|
|
The Outlook for Pharmaceuticals in Northern Europe
By: Espicom Healthcare Intelligence
The Northern European countries are projected to represent a combined pharmaceutical market value of over US$27 billion at retail prices by 2016. Please note, this file is delivered as an Zip file.
|
more...
|
11/4/2011
|
$3,490.00
|
|
The Outlook for Pharmaceuticals in Western Europe
By: Espicom Healthcare Intelligence
... market. Growth, however, will be tempered somewhat by the effects of the global economic recession in the short term. The leading markets are projected to average a CAGR of 2.5% in US dollar terms up ...
|
more...
|
11/4/2011
|
$3,490.00
|
|
The Pharmaceutical Market: Egypt
By: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...
|
more...
Search inside this report
|
10/31/2011
|
$1,040.00
|
|
The Pharmaceutical Market: Russia
By: Espicom Healthcare Intelligence
... for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators. Specialised intelligence on OTCs, generics, biologics and biosimilars. Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the ...
|
more...
Search inside this report
|
10/31/2011
|
$1,040.00
|
|
The Outlook for Medical Devices in South East Asia
By: Espicom Healthcare Intelligence
... still maintaining good growth levels, the markets of SE Asia offer enterprising companies good opportunities. However, they must meet the challenges of widely differing operating environments. Please Note: this is delivered as a Zip file.
|
more...
|
10/31/2011
|
$3,490.00
|
|
Title
|
Published
|
Price
|